Safety and tolerability of pasireotide long-acting release in acromegaly-results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study
about
Safety and tolerability of pasireotide long-acting release in acromegaly-results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Safety and tolerability of pas ...... medical therapy (ACCESS) study
@en
Safety and tolerability of pas ...... edical therapy (ACCESS) study.
@nl
type
label
Safety and tolerability of pas ...... medical therapy (ACCESS) study
@en
Safety and tolerability of pas ...... edical therapy (ACCESS) study.
@nl
prefLabel
Safety and tolerability of pas ...... medical therapy (ACCESS) study
@en
Safety and tolerability of pas ...... edical therapy (ACCESS) study.
@nl
P2093
P2860
P1433
P1476
Safety and tolerability of pas ...... medical therapy (ACCESS) study
@en
P2093
ACCESS Study Investigators
Elisha Rusch
Eliza B Geer
Maria Fleseriu
P2860
P2888
P304
P356
10.1007/S12020-016-1182-4
P577
2016-11-28T00:00:00Z